Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $5,166 MXN
Change Today +9.00 / 0.17%
Volume 1.5K
As of 4:09 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stuart A. Kingsley

Executive Vice President of Global Commercial Operations, Biogen Inc.
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 5 different industries.

See Board Relationships
51--
As of Fiscal Year 2013

Background*

Mr. Stuart A. Kingsley, also known as Tony, has been an Executive Vice President of Global Commercial Operations at Biogen Inc. since November 7, 2011. Mr. Kingsley served as Senior Vice President of US Commercial Operations at Biogen Idec Inc. from January 2010 to November 7, 2011. He served as the President of GYN Surgical Products of Hologic Inc. since October 2007. He joined Hologic Inc. in October 2007 in connection with Hologic Inc.'s merger with Cytyc. Mr. Kingsley ...

Read Full Background

Corporate Headquarters*

225 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-679-2000
Fax: --

Board Members Memberships*

Member of the Board

Education*

BA
Dartmouth College
MBA
Harvard Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIIB*:MM $5,166.00 MXN +9.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.3M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.4M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥182.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.